REHMAN, E. et al. High Risk of Cardiovascular Events in Patients, Biosynthesis of Aspirin-Resistant Thromboxane And The Risk Of Stroke, Myocardial Infarction Or Death: Biosynthesis of Aspirin-Resistant Thromboxane & Risk of Stroke. Pakistan BioMedical Journal, v. 5, n. 6, p. 213–218, 30 Jun.2022.